SJ
Sunita Jolly
About Sunita Jolly
Data last updated:
Sunita Jolly is a Director at Supriti Pharmaceuticals Private Limited (since 2020). The company operates in Chemicals. Supriti Pharmaceuticals Private Limited reported revenue of ₹59.9 Lakh (FY 2022).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Supriti Pharmaceuticals Private Limited U24239UR2020PTC011868 | Director | 14 Dec 2020 | 2020 | ₹59.9 Lakh (FY 2022) | Active |
Board colleagues of Sunita Jolly
| Name | DIN | Company | Designation |
|---|---|---|---|
| Amit Suri | 09019693 | Supriti Pharmaceuticals Private Limited | Director |
| Nishad Arora | 09019707 | Supriti Pharmaceuticals Private Limited | Director |
| Preetika Suri | 08994777 | Supriti Pharmaceuticals Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Sunita Jolly
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Sunita Jolly
Sunita Jolly currently holds 1 directorship: Supriti Pharmaceuticals Private Limited (Director, since 14 Dec 2020, revenue ₹59.9 Lakh (FY 2022)).
Sunita Jolly was first appointed on 14 Dec 2020 as Director at Supriti Pharmaceuticals Private Limited.
The current boards of Sunita Jolly's companies include Amit Suri (Supriti Pharmaceuticals Private Limited), Nishad Arora (Supriti Pharmaceuticals Private Limited), Preetika Suri (Supriti Pharmaceuticals Private Limited).